• Nightfood is revolutionizing the way people snack at night
• The company recently announced upcoming production runs in May and June, totaling over 330,000 pints, to prepare for new national distribution deal
• Nightfood Holdings CEO Sean Folkson described the company’s upcoming ventures in a SmallCapVoice.com interview

Nightfood Holdings Inc. (OTCQB: NGTF), an innovative consumer goods and brand development company, is pioneering the category of “sleep-friendly” nutrition with the national roll-out of its award-winning Nightfood ice cream. Leading marketing intelligence agency Mintel noted that nighttime-specific food and beverages represent one of the “most compelling and category changing” trends for the coming years (http://ibn.fm/fBtZr). Nightfood aims to revolutionize the way Americans snack at night.

Nightfood founder and CEO Sean Folkson was featured last week in an interview hosted by Stuart Smith of SmallCapVoice.com. In the interview, Folkson discussed Nightfood ice cream’s national rollout through major supermarket chains such as Meijer and Lowes Foods. Folkson also discussed a new distribution deal that he expects to have a massive impact on distribution and revenue in 2019 and beyond.

“We have a deal that we’re expecting to sign in the next couple of days that’s going to dramatically expand our footprint immediately, [bringing] us coast-to-coast right here in 2019,” Folkson said in a news release (http://ibn.fm/Xh8tR). “I’m projecting that it’s going to bring exponential growth to us in the next several quarters.”

Now that the company has publicly announced that this distribution deal has been signed, it is ramping up production to fulfill projected demand (http://ibn.fm/vGDwj). In the next 60 days, the company plans to produce over 330,000 pints of ice cream, enough for well over $1 million in revenue.

Jim Christensen is Nightfood’s VP of ice cream sales. Christensen spent more than 20 years at Unilever, where he held the same position and headed up sales and distribution initiatives for Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen noted in a release that the company anticipates monthly production runs with ever-increasing run volumes.

Folkson also recently discussed his company’s approach to social media marketing. He described “investomers” as individuals who both have an ownership stake in a company and also consume its products, and he believes that the “growing army of Nightfood investomers will accelerate the word-of-mouth [brand awareness] that so often catapults innovative new brands into public awareness and national distribution.”

Researchers estimate that most at-home ice cream consumption occurs in the hours before bed. The team at Nightfood, which includes America’s most prominent sleep expert, Dr. Michael Breus, has created an ice cream line specifically designed for nighttime snackers.

Recently, Nightfood ice cream was announced as the winner of the 2019 ‘Product of the Year’ award in the ice cream category in a survey of more than 40,000 consumers (http://ibn.fm/IAjjG).

For more information, visit the company’s website at www.Nightfood.com

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• SPRWF has remained at the center of the cannabis space since 2014
• The company has a licensed producer subsidiary in Ontario
• Supreme Cannabis recently launched new subsidiary Cambium Plant Sciences
• Bank of America recently initiated coverage with an initial ‘Buy’ rating

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) is Canada’s only large-scale premium cannabis producer. The company formed its wholly owned 7ACRES subsidiary as the first licensed producer (“LP”) centered on growing high-quality cannabis in high quantities. 7ACRES provides enthusiasts with handcrafted cannabis flower that delivers a premier experience. Headquartered in Toronto, Supreme Cannabis has supply agreements in place throughout eight of the 10 Canadian provinces.

Supreme Cannabis’ 7ACRES operates a 440,000-square-foot facility in Kincardine, Ontario, including licensed flower room space totaling 180,000 square feet. 7ACRES is on course to become Canada’s foremost cultivator of consistently first-rate commercial cannabis. With its recently-expanded flowering room, 7ACRES’ yearly production capacity estimate increased from roughly 17,500 kg to 26,250 kg. The company expects that, with additional production efficiencies following the licensing of all 25 of its flowering rooms, 7ACRES’ potential capacity could reach about 50,000 kg annually (http://ibn.fm/BqnC3).

In addition to 7ACRES, Supreme Cannabis’ brands include wholly owned subsidiary Cambium Plant Sciences, a cannabis genetics firm. The company recently announced the launch of Cambium Plant Sciences, which is located in Goderich, Ontario (http://ibn.fm/aHYAF). Additionally, its brands include a worldwide partnership with Khalifa Kush Enterprises (“KKE”), led by musician Wiz Khalifa, and its investment in Medigrow Lesotho.

Supreme Cannabis’ strategic agreement with KKE is for cannabis-related consulting services and the development and commercialization of distinct product lines (http://ibn.fm/Ki4qs). KKE will provide cannabis-related consulting services to Supreme Cannabis, while SPRWF will be the exclusive producer of KKE-branded products in Canada and, subject to certain approvals, globally, excluding the United States (http://ibn.fm/zFaf7).

In 2018, Supreme Cannabis entered into a definitive agreement to complete a $10 million strategic equity investment in Medigrow Lesotho (PTY) Limited. Medigrow Lesotho is a federally-licensed producer of cannabis in the Kingdom of Lesotho in southern Africa. Via this distribution partnership, CBD (cannabidiol) oil is expected to be exported to Canada and other global markets in the European Union and South America. Medigrow is licensed by the Lesotho Ministry of Health to cultivate and manufacture medical cannabis and cannabis oil products (http://ibn.fm/w2nIo).

In conjunction with Supreme Cannabis’ recent launch of Cambium Plant Sciences, the company is investing approximately $14 million in the construction of a state-of-the-art, 34,000-square-foot research and development facility in Goderich. Cambium’s aim is to lead the agricultural revolution of cannabis genetics, redefining consumer experiences and cultivation economics across the international cannabis industry.

“Cambium will develop cultivars that benefit our in-house brands, as well as our domestic and global cultivation and manufacturing partners,” Navdeep Dhaliwal, Supreme Cannabis’ CEO, stated in a news release. “Initially, Cambium is expected to benefit from 7ACRES’ established genetics, existing infrastructure and unparalleled plant knowledge of its team.” The expectation is that Supreme Cannabis will begin the retrofitting of the Cambium facility in early summer of this year. Moreover, Cambium Plant Sciences has begun the Health Canada licensing process.

In addition, on April 17, 2019, Bank of America Merrill Lynch (“BofA”) announced the initiation of coverage of the company with a ‘Buy’ rating and a C$2.50 price objective, according to an official coverage initiation announcement issued by the investment bank.

According to BofA, there are several factors that contribute to the attractiveness of Supreme Cannabis. Approximately 80 percent of the Supreme Cannabis production is sold in Canada. Supreme is selling in bulk at a similar price range to that of its peers in retail. This means that the Supreme Cannabis pricing model is the same, but the margin delivery format is higher. Moreover, Supreme Cannabis trades at the low-end of the BofA coverage group on E/V sales, which makes it attractive on DCF. BofA estimates that Supreme Cannabis sales will grow from C$9 million in 2018 to C$234 million in 2022. The growth on an annual basis will be 234 percent in 2020, slowing down to 64 percent in 2021 and 36 percent in 2022. Gross profits are also set for growth, from C$2 million in 2018 to C$131 million in 2022, at a rate of over 263 percent in 2020, 91 percent in 2021 and 44 percent in 2022, according to BofA estimates.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

• Branded cannabis products grew 637 percent more than non-branded products between 2014 and 2018
• Edibles continue to assure investors of stable market prices as compared to concentrates and flower products
• Plus Products anticipates enormous growth in production capacity as it constructs a large-scale manufacturing plant

Leading California edibles manufacturer Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) is making moves to dominate the branded cannabis industry through its continued focus on premium products executed with precision and made available to consumers everywhere.

The team at Plus Products realizes that the cannabis industry is moving toward branded products and sees brand strategy as key to accessing strong profit growth. In California alone, non-branded cannabis products grew by 64 percent between Q1 2014 and Q1 2018, while branded products saw retail growth of 701 percent in that same period. The company sees brand recognition as an integral component to its continued success in this market.

Looking forward, Plus Products is maintaining its focus on edibles, a segment that is on an upward trend. Between 2014 and 2018, the edibles market in Colorado alone rose from 12 percent to 16 percent of the cannabis space; in California, its market share rose from 13 percent to 16 percent between 2017 and 2018 (http://ibn.fm/Q6icJ). In addition, the edibles price point has shown steady growth since 2014, while various other products, such as concentrates and flower, have shown a steep decline, clearly distinguishing edibles as a product type that could be worthy of long-term investment.

Notably, Plus Products was ranked as the number one edibles brand in California as of Q3 2018, according to data from both BDS Analytics and Headset, achieving impressive retail success in the world’s most competitive cannabis market (http://ibn.fm/CpC9x). Currently, California offers the most competitive climate for cannabis companies, hosting almost 250 different edible brands while Colorado has less than 100. California is also the largest cannabis market worldwide, and it’s expected to grow to $5 billion in 2019 legal sales (http://ibn.fm/D6KoR).

BDS Analytics and Headset also report that Plus Products’ unit sales have grown 97 percent from Q2 2018 to Q3 2018. Moreover, Plus Products anticipates the construction of “the largest food grade manufacturing plant in the state with room to expand,” enabling the potential for $450 million in production capacity (http://ibn.fm/mfszZ). The company’s goal is to own the branded product space by pairing disciplined, agile food manufacturing with thoughtful branding teams.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• Trxade Group helps independent pharmacies identify the best supplier prices for prescription drugs
• The company’s trading platform allows independent pharmacies to stay informed about up-to-the-minute pricing on a cost-effective basis
• Trxade provides its services to pharmacies and consumers

An integrated pharmaceutical services company, Trxade Group Inc. (OTCQB: TRXD) offers an S2P (Supplier to Pharmacy) market platform. The platform helps independent pharmacies operating nationwide to identify the best available supplier prices for prescription drugs. Trxade is the largest online pharmaceutical marketplace platform in the United States. Per corporate data, the platform has been shown to reduce a pharmacy’s total yearly purchase costs by 7-10 percent (http://ibn.fm/vMKt1).

Headquartered out of Land O’ Lakes, Florida, Trxade Group brings pharmaceutical buyers and sellers together. The company’s strategy is to use price analytics and supplier competition to pass considerable advantages directly to its members. Its focus is on the best pricing and availability of generic and branded pharmaceuticals. Trxade’s platform maintains a wide-ranging generic and branded pharmaceutical portfolio that is accessible to community pharmacies across the nation.

The Trxade platform allows a third of the approximately 24,000 independent pharmacies in the United States to keep abreast of up-to-the-minute pricing on a cost-effective basis. Pharmacies pay no membership or transaction fees for using the platform, which offers access to numerous supplier sources. In addition, the platform has an easy layout for price comparison and purchasing. Trxade Exchange also opens and expands the distribution channel to retail and community pharmacies (http://ibn.fm/NwZid).

Trxade Group earns a transaction fee from sellers on the trading platform. The company charges 5 percent on each transaction value for generic drugs and 0.25 percent for branded drugs. Trxade Group also focuses on the consumer side of the pharmaceutical industry, offering drug price transparency and efficient buying. The company also facilitates delivery of drugs directly to independent pharmacists and consumers, operating a full-service mail order pharmacy for U.S. consumers. Furthermore, the Trxade Group Delivmeds mobile app enables same-day home delivery of dispensed prescriptions.

The company also offers RX Guru (http://ibn.fm/J7zmB). This price-prediction model integrates product shortage insight into pharmacy acquisition benchmarks to determine trends and pricing variances that could result in major purchasing opportunities. Fundamentally, RX Guru provides its members with an opportunity to benefit from real price-purchasing opportunities that are often concealed from the rest of the industry.

With its proprietary technology and extensive database, Trxade Group is poised to further penetrate its target market of independent pharmacies and their $93 billion of annual purchases. For investors, the company offers the potential for significant returns due to its low-risk, high-return business model. With a strategy focused on adding new industry sectors, such as hospitals, veterinarians and long-term care, Trxade Group continues to advance its initiatives for organic growth.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD

• Petroteq is strategically expanding its oil sands resource through the acquisition of operating rights and interests under U.S. federal oil and gas leases
• The agreement encompasses 8,480 gross acres in Utah; the new agreement and a previous one will give Petroteq 100 percent operating rights for oil sands development
• Expert estimates establish a significant oil/bitumen resource at both the Tar Sands Triangle and the P.R. Springs federal oil and gas leases
• The move is the latest step in what is seen as a potential revolution in the oil industry, using Petroteq’s patented technology to efficiently capture heavy oil that was not previously accessible

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF), a fully integrated oil and gas company, announced on April 16, 2019, that it is executing a definitive agreement for the acquisition of an additional 50 percent of the operating rights and interests relating to oil sands in the state of Utah, under U.S. federal oil and gas leases.

The U.S. federal oil and gas leases encompass approximately 8,480 gross acres (4,240 net acres), the company said in a news release (http://ibn.fm/1YaWA). This acquisition, as well as the previous one carried out by Petroteq for 50 percent of the operating rights and interests under the same lease, will give the company 100 percent of the operating rights for oil sands development.

As per the acquisition terms and conditions, Petroteq’s wholly owned subsidiary, TMC Capital LLC, will acquire Petrollo LP Corp. – a Nevada corporation with an undivided 50 percent interest in the operating rights under a federal oil and gas lease located in P.R. Springs and five federal and oil gas leases located in the Tar Sands Triangle.

Under all of the leases, the operating rights include the right to explore for and produce bitumen and heavy oil from oil-impregnated bituminous sand formations.

According to Chapman Petroleum Engineering Ltd., estimates suggest that all of the operating rights interests acquired under the P.R. Springs lease will give Petroteq access to a gross contingent resource of 90 million barrels of mineable oil/bitumen. The arithmetic average after risk estimate is set at 40.77 million barrels of mineable bitumen/oil.

The remaining operating rights for the Tar Sands Triangle lease are estimated to contain 41.3 million barrels of in situ oil/bitumen. The arithmetic average after risk is 20.7 million barrels.

According to Petroteq CEO David Sealock, the acquisition is a part of the company’s oil sands acquisition strategy focused on the state of Utah and including federal leases that cover lands and areas deemed as special tar sand areas.

Petroteq is focused on the development and implementation of new proprietary technologies for oil extraction. The environmentally safe and sustainable approach for the extraction of heavy oil and bitumen from oil sands, shale and shallow oil deposits produces zero greenhouse emissions or waste and does not necessitate the use of high temperatures. The successful processing of oil from such deposits represents a potential revolution in the oil industry, much as fracking did before, and could represent a huge step forward.

As a part of its expansion strategy, Petroteq is currently focused on increasing its oil sand resources and expanding the company’s production capacity at the Asphalt Ridge heavy oil extraction facility. Crude oil processing at Asphalt Ridge started last year, and, recently, the company announced that it has achieved two weeks of continuous production using its proprietary technology at a benchmark level.

In the beginning of 2019, the Asphalt Ridge facility underwent an expansion aimed at increasing its production capacity to 1,000 barrels per day. Currently, the company is preparing to move the facility into the second stage of its production lifecycle, with an aim of reaching 4,000 barrels per day by the end of Q1 2020. Notably, permit approval has not been received as planned; it was expected in Q1 2019.

For more information, visit the company’s website at www.Petroteq.energy

NOTE TO INVESTORS: The latest news and updates relating to PQEFF are available in the company’s newsroom at http://ibn.fm/PQEFF

• Siyata is a leading global developer and provider of cellular communications systems
• Company recently launched the world’s first 4G LTE all-in-one fleet communications device, marketed under the Uniden Cellular brand
• Details of Siyata’s first purchase order from a Tier 1 U.S. cellular carrier as an official vendor are forthcoming
• Siyata is a TSX Venture Top 50 Company, and it has already launched in Canada with Bell Canada

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of cellular communications solutions for enterprise customers. Siyata specializes in connected vehicle products marketed under the Uniden Cellular brand for professional fleets. The company announced its first purchase order from a Tier 1 U.S. cellular carrier for its flagship product, the Uniden UV350, in a news release issued early last month (http://ibn.fm/8GTOZ). Details of the commercial launch of the Uniden UV350 in the U.S. will be announced shortly, according to Marc Seelenfreund, CEO of Siyata Mobile.

“Siyata is not only first to market but has created a completely new device category, likened to the rugged phone, the rugged tablet and feature phone categories all which sold millions of devices through Tier 1 U.S and global carriers,” Seelenfreund stated in the news release. “The UV350 represents a completely untapped yet equal opportunity which meets the needs of First Responder and commercial vehicles around the world and we are excited to be included in the ranks of the leading global cellular vendors.”

In its 2018 National Transportation Statistics report, the U.S. Department of Transportation notes that there are more than 12.6 million commercial vehicles on the road. The commercial vehicle market, which includes several million first responder vehicles, is predicted to continue its steady growth (http://ibn.fm/tDT2D). The nation’s freight transportation system moved nearly 17.7 billion tons of goods, valued at more than $18.1 trillion, in 2016, the report states, with trucks carrying the largest share of goods shipped.

Siyata’s opportunity in this sector is massive, given the potentially large number of commercial vehicles that need to replace an aging two-way LMR technology with push-to-talk over cellular (“PoC”) technology. The Uniden UV350 was designed specifically for commercial vehicles to ensure safer communication for professional drivers. It is the first 4G/LTE all-in-one in-vehicle fleet communication device that delivers crystal clear cellular voice calls, push-to-talk over cellular, data applications and more (http://ibn.fm/vEu26).

Siyata aims to become the connected vehicle communications device of choice for commercial fleets and first responders around the world. The company also offers rugged phones for industrial users and signal boosters for homes, buildings and fleets with poor cell coverage. Siyata’s customers include cellular operators, commercial vehicle technology distributors and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

For more information, visit the company’s website at www.SiyataMobile.com

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

• As the anticipated legalization of edible cannabis products approaches in Canada, Sproutly is developing an infused beverage lineup by entering into a joint venture with Canadian beer maker Moosehead Breweries
• The JV creates a standalone company drawing on Sproutly’s water-soluble Infuz2O technology and Moosehead’s decades of beverage market experience
• The proprietary Infuz2O technology offers the advantage of a controlled rapid-on/rapid-off effect, similar to recreational cannabis use but without being smoked
• The cannabis-infused beverage market is expected to generate revenues in the billions by 2024 as consumers seek alternatives to alcohol

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) will lend its technological breakthrough in naturally produced, water-soluble cannabinoids to a joint venture with one of Canada’s oldest and largest independent breweries to create a line of non‐alcoholic cannabis-infused beverages, anticipating the legalization of edible forms of cannabis in Canada later this year.

The joint venture between Sproutly and OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited, will be structured as a standalone company with its own board of directors and management team. Sproutly and Moosehead are working through the legal details of the venture, but they expect to have it up and running by May 31, as stated in a news released detailing the plans (http://ibn.fm/tRQzF).

The joint venture’s product line will utilize Sproutly’s proprietary Infuz2O water-soluble cannabis formulation to create a truly natural cannabis beverage experience that serves as an alternative to alcoholic products. The Infuz2O technology is expected to grant the beverages a rapid onset and offset time similar to traditional flower cannabis, for an immediate, controllable and good-tasting recreational cannabis experience lasting up to 90 minutes. Traditional cannabis oils, on the other hand, may last for hours and have a more unpredictable duration.

Moosehead, in turn, will lend its respective strengths to the venture, providing proven ability in building, marketing and selling beer on an international scale over the course of more than 150 years.

“With the anticipated legalization of edibles in Canada later this year, Moosehead has made the strategic decision to enter the cannabis beverage market,” Moosehead CEO Andrew Oland stated in a news release. “As a 152 year old company spanning six generations, we are very selective about new business opportunities. After a significant amount of due diligence on Sproutly’s APP technology and Infuz2O water soluble cannabinoids vs other competitive technologies, we are excited to announce this joint venture. With their advanced technology and our long-standing product development experience, we expect to bring to Canadian consumers cannabis beverages that address the major issues currently limiting appeal of this category in other markets.”

Each company will hold a 50 percent interest in the JV and have the right to nominate three directors. Moosehead executive Matthew Oland has been named incoming CEO of the venture, and Sproutly will determine the board chairperson. The contract for Sproutly’s exclusive Infuz2O service will last five years, with the potential for extension as revenue targets are met.

“This partnership with Moosehead marks an important milestone in Sproutly’s mission of delivering a safe and consistent whole plant experience from cannabis, with a lead position in the beverage market,” Sproutly CEO Keith Dolo added. “We have developed a relationship with Moosehead built on trust and our shared vision of creating safe, responsible and high-quality cannabis beverages and we look forward to making this a reality for Canadian consumers.”

A presentation on the JV (http://ibn.fm/P6zfY) states that the beverages will initially be marketed only in Canada, maintaining the ability to enter the European market if and when edible recreational cannabis use is legalized there.

In early April, Sproutly announced that wholly owned subsidiary Toronto Herbal Remedies Inc. (“THR”) had been granted a processing license from Health Canada that allows THR to produce cannabis oil and related products (http://ibn.fm/fmFqX). The license allows Sproutly to extend development of the cannabis strain formulations that the company plans to use in its cannabis beverages and to perform shelf-stability and other necessary testing in anticipation of legalized edibles.

Deloitte researchers predict that the cannabis-infused beverages sector will reach somewhere between $900 million and $4.4 billion by 2024, depending on the percentage of the market it captures (http://ibn.fm/tug3z).

For more information, visit the company’s website at www.Sproutly.ca

NOTE TO INVESTORS: The latest news and updates relating to SRUTF are available in the company’s newsroom at http://ibn.fm/SRUTF

• LXRP CEO Chris Bunka and President John Docherty have agreed to new, three-year contracts
• The new contract agreements are designed to provide management security with continuity of key officers
• The company recently canceled 1,140,000 stock options after negotiations with optionees

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has successfully negotiated new three-year compensation contracts with key officers Chris Bunka, CEO, and John Docherty, president. The agreements offer LXRP and its shareholders the security of pursuing corporate growth within a seamless transition by providing management continuity. The renewal agreements are retroactive to January 1, 2019 (http://ibn.fm/V8SmJ).

The agreements offer both officers compensation and bonuses based on meeting certain performance criteria established by the LXRP board. The agreements also offer a one-time bonus based on consideration for the sale of any subsidiary or change of control, excluding certain circumstances, as well as continuing participation in the LXRP stock option plan.

LXRP also announced that, effective April 5, 2019, the company was canceling 1,140,000 stock options with exercise prices ranging from $0.10 to $2.06 after reaching agreements with certain optionees.

Based in British Columbia, Canada, LXRP is a biotechnology company and drug-delivery platform innovator, with DehydraTECH as its proprietary absorption technology platform. The company has developed and out-licenses its disruptive technology, which promotes healthier ingestion methods and lower overall dosing. LXRP holds a patent for oral delivery of all cannabinoids and has a growing IP portfolio that includes 10 patents granted in the United States and Australia and more than 50 patent applications worldwide across 10 patent families.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• The company provides fully and partially owned firms with the same management efforts and mentorship services
• Its Blue Ocean Strategy is pushing SHRG forward with sustained revenue growth
• SHRG expanding into Canada is the first step in a larger international expansion plan

Sharing Services Global Corporation (OTCQB: SHRG) owns, operates or controls interests in direct-selling companies. The company’s diversified portfolio allows it to reshape how today’s entrepreneur achieves success through a model that provides management, buying power, merchant processing, manufacturing and administrative services to already established direct-selling and network-marketing firms.

By leveraging the abilities of numerous direct-selling and network-marketing businesses, SHRG is able to offer products and services directly to the consumer through Elepreneurs, or independent representatives. Elepreneurs is a term coined by SHRG that summarizes the company’s mission of elevating today’s entrepreneurs by revolutionizing the direct-selling industry.

To do this, SHRG created its blue ocean strategy. The goals of SHRG’s blue ocean strategy are threefold:

1. Elevate home-based entrepreneurs;
2. Utilize the direct-selling channel to generate 100 percent organic growth; and
3. Create successful independent business leaders.

The company has already seen rapid growth from this strategy. In January 2019, SHRG reported approximately 29,000 Elepreneurs and 200,000 customers. The combination of quality products, the excellent performance of Elepreneurs and the continued satisfaction of customers have played a vital role in SHRG’s performance.

“We [are] on track for a great first full year since launching our incredible health and wellness division of Elevacity Global and Elepreneurs,” Sharing Services CEO John “JT” Thatch stated in a recent press release (http://ibn.fm/EbMq3). “March sales revenues are proof that our Blue Ocean Strategy is being well accepted in the direct-selling marketplace. We look forward to closing out our year-end this month, while expanding into Canada for further growth opportunities.”

The company has aggressive plans to expand rapidly and increase revenues. Earlier this year, the company changed its name from Sharing Services Inc. to Sharing Services Global Corporation to better represent its global expansion plan. The next step in its international strategy involves plans for Elepreneur LLC to expand into Canada. The company’s first Canadian event is scheduled to take place on May 3-4 in Ottawa, Ontario.

Management notes that integrity, respect and dedication are at the heart of all that SHRG does. The company intends to continue to share its great products and services by utilizing its blue ocean strategy in the United States and as it expands globally.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• Company’s TV spot recently aired on Fox News, Lifetime and the Cooking Channel
• A Shark Tank entrepreneur introduces the commercial by explaining how ETST can address ‘aches and pains’
• Infomercial campaign is also available online and on social media

Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, is airing its ‘As Seen On TV’ infomercial in the New York market. During the 60-second spot, entrepreneur Kevin Harrington, an original shark on Shark Tank, explains that ETST’s full-spectrum cannabinoids can help with ‘aches and pains’ (http://ibn.fm/qWL1I).

The infomercial (http://ibn.fm/bmE3x) is highly personal, focusing on the improvement in lifestyle of real-life ETST customer Rhoda Friedman. During the ad, Friedman notes how using Earth Science Tech products freed up her movement and improved her lifestyle. The spot explains how case studies have proven that full-spectrum cannabinoids, derived from industrial-grade hemp, can reduce pain and inflammation and improve sleep. The ad also notes that consumers can purchase ETST products online or in local health foods stores.

ETST announced that markets and networks will be added to the infomercial campaign, which is scheduled to run through July 14. Initially airing in New York on Fox News, Lifetime and the Cooking Channel, the spot may also be seen online and on social media. It airs between 9 p.m. and midnight Eastern. New York was selected as the initial market, because it is one of the largest consumer-based areas in the United States, ETST officials noted.

“I am really excited that we have completed production and are now able to share Rhoda Friedman’s amazing story with the world,” Nickolas S. Tabraue, ETST’s president and chairman, said in a news release. “We are passionate about our products and the life-changing potential they offer.” Tabraue also praised Kevin Harrington’s team.

ETST’s full-spectrum cannabinoids offer analgesic pain relief and anxiety reduction, the company aded. ETST offers cannabinoids in the form of soft gels, tablets, liquids and other forms classified as food-based, with the products being permissible in all 50 states in the United States and some 40 countries.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST